Supha Pharmachem LtdBSE: SUPHA

Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

· Issued by Supha Pharmachem Ltd via BSE India

Filed with BSE ·

Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2025 ,inter alia, to consider and approve raising funds by way of issue of fresh equity shares through Right Issue basis along-with other matter, if any, as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required.2) Any other business with the permission of the Chair.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Supha Pharmachem Ltd on 6ix

Earlier from Supha Pharmachem

Later from Supha Pharmachem

All Supha Pharmachem news releases